1 Podcast Episodes
Long-term outcomes with ruxolitinib and best available therapy for the treatment of myelogibrosis: Dr Alessandro Vannucchi
Long-term outcomes with ruxolitinib and best available therapy for the treatment of myelogibrosis: Dr Alessandro Vannucchi
Prof Alessandro Vannucchi talks to ecancer at the 18th EHA Congress in Stockholm about a phase III clinical trial that e... Read more
20 Jun 2013
•
8mins